224 related articles for article (PubMed ID: 6804848)
21. [Trials of auricular defibrillation with the quinidine-verapamil combination by oral route].
De Soldati L; Stritzler G; Balassanian S; Fuksman A; Mario Krasnov C; Rosental R; Chutlian A; Fabregas R
Prensa Med Argent; 1972 May; 59(17):665-70. PubMed ID: 5048460
[No Abstract] [Full Text] [Related]
22. [Treatment of supraventricular tachycardia].
Peters RW
Recenti Prog Med; 1981 Jul; 71(1):48-68. PubMed ID: 6118917
[No Abstract] [Full Text] [Related]
23. [Late results of treating auricular flutter and fibrillation using controlled cardiac phasic electroshock].
Betz GG; Olesch K; Schmidt-Voigt J
Kardiologiia; 1971 Feb; 11(2):48-53. PubMed ID: 5568391
[No Abstract] [Full Text] [Related]
24. [Quinidine and verapamil combination therapy for the treatment of atrial arrhythmias].
Kleinebenne A; Mannebach H; Gleichmann U
Fortschr Med; 1981 Oct; 99(38):1569-74. PubMed ID: 7297996
[No Abstract] [Full Text] [Related]
25. [A new anti-arrhythmic agent: a prolonged-action derivative of quinidine].
Warembourg H; Ducloux G
Lille Med; 1971 Jan; 16():Suppl 1:234-7. PubMed ID: 5162045
[No Abstract] [Full Text] [Related]
26. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].
Zehender M; Meinertz T; Just H
Z Kardiol; 1994; 83 Suppl 5():101-8. PubMed ID: 7846938
[TBL] [Abstract][Full Text] [Related]
27. [Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].
Patten M; Koch HP; Sonntag F; Lüderitz B; Meinertz T
Z Kardiol; 1999 Mar; 88(3):185-94. PubMed ID: 10355069
[TBL] [Abstract][Full Text] [Related]
28. [Comparative antiarrhythmic activity of beta-N-hexamethyleneimino-P-butoxypropiophenone, quinidine and novocaine amide in aconitine auricular fibrillation and flutter in cats].
Ammar EM; Kudrin AN
Farmakol Toksikol; 1969; 32(4):415-8. PubMed ID: 5357458
[No Abstract] [Full Text] [Related]
29. Invited letter concerning: amiodarone and quinidine for postoperative atrial arrhythmias.
Kay GN
J Thorac Cardiovasc Surg; 1990 May; 99(5):942. PubMed ID: 2278544
[No Abstract] [Full Text] [Related]
30. Clinical effects of verapamil in cardiac arrhythmias.
Antani JA; Sriniwas HV
J Assoc Physicians India; 1972 Nov; 20(11):815-9. PubMed ID: 4120284
[No Abstract] [Full Text] [Related]
31. Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.
Sung RJ; Waxman HL; Elser B; Juma Z
Clin Invest Med; 1980; 3(1-2):41-7. PubMed ID: 7009003
[No Abstract] [Full Text] [Related]
32. [The differentiated therapy of paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease in relation to the duration of the arrhythmia before the start of treatment].
Shabrov AV; Olesin AI; Golub IaV; Smolin ZIu
Ter Arkh; 1998; 70(8):25-9. PubMed ID: 9770739
[TBL] [Abstract][Full Text] [Related]
33. [Adrenergic beta blockaders and cardiac arrhythmias. Combination propranolol-quinidine in the treatment of chronic atrial fibrillation].
Milone P; Anselmino A
Minerva Cardioangiol; 1974 Sep; 22(9):623-33. PubMed ID: 4607995
[No Abstract] [Full Text] [Related]
34. [Clinical experience with a combination of a new beta-blocking agent, LB 46, and quinidine in the treatment of chronic atrial fibrillation].
Levi GF; Proto C
Minerva Cardioangiol; 1972 Feb; 20(2):92-5. PubMed ID: 4401589
[No Abstract] [Full Text] [Related]
35. [Life-threatening disorders of the heart rhythm and beta receptor blocking agents].
Tschirdewahn B; Knorpp K; Heinrich F; Schütterle G
Dtsch Med Wochenschr; 1967 Dec; 92(48):2204-8. PubMed ID: 6057149
[No Abstract] [Full Text] [Related]
36. The treatment of atrial fibrillation and flutter: a review.
Willoughby ML; Dunlap DB
Heart Lung; 1984 Sep; 13(5):578-84. PubMed ID: 6147326
[No Abstract] [Full Text] [Related]
37. Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.
Rabkin SW; Tomlinson C; Corbett BN; Cuddy TE
Can Med Assoc J; 1980 Jan; 122(1):64-8. PubMed ID: 7363198
[No Abstract] [Full Text] [Related]
38. [Paroxysmal atrial fibrillation and flutter and "occult" arterial hypertension. The importance of the ambulatory monitoring of the blood pressure. Apropos 2 cases].
Carmona J; Amado P; Castanheira J; Nazaré J; Araújo V
Rev Port Cardiol; 1993 Oct; 12(10):865-70, 806. PubMed ID: 8286135
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacotherapy of paroxysmal tachycardia].
Theisen K
Dtsch Med Wochenschr; 1983 Jul; 108(26):1021-7. PubMed ID: 6133733
[No Abstract] [Full Text] [Related]
40. [Value of the quinidine propranolol association in the treatment of atrial fibrillation].
Duchene-Marullaz P; Pignide L; Chollet P
Presse Med (1893); 1971 Apr; 79(18):814. PubMed ID: 5089783
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
